Meyka AI API is live for developers.Start building.
Advertisement
VSee Health, Inc.

VSee Health, Inc. Fundamental Analysis

VSEEWNASDAQ
HealthcareMedical - Healthcare Information Services
$0.04
$0.003(7.59%)
U.S. Market opens in 54h 29m
Advertisement

VSee Health, Inc. Fundamental Analysis

VSee Health, Inc. (VSEEW) shows moderate financial fundamentals with a PE ratio of -0.55, profit margin of -92.37%, and ROE of -115.71%. The company generates $0.0B in annual revenue with strong year-over-year growth of 78.42%.

Key Strengths

Cash Position70.78%
PEG Ratio-0.00

Areas of Concern

ROE-115.71%
Operating Margin-66.23%
Current Ratio0.41
We analyze VSEEW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -11600.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-11600.8/100

We analyze VSEEW's fundamental strength across five key dimensions:

Efficiency Score

Weak

VSEEW struggles to generate sufficient returns from assets.

ROA > 10%
-70.22%

Valuation Score

Excellent

VSEEW trades at attractive valuation levels.

PE < 25
-0.55
PEG Ratio < 2
-0.00

Growth Score

Moderate

VSEEW shows steady but slowing expansion.

Revenue Growth > 5%
78.42%
EPS Growth > 10%
-5.73%

Financial Health Score

Moderate

VSEEW shows balanced financial health with some risks.

Debt/Equity < 1
0.26
Current Ratio > 1
0.41

Profitability Score

Weak

VSEEW struggles to sustain strong margins.

ROE > 15%
-11570.74%
Net Margin ≥ 15%
-92.37%
Positive Free Cash Flow
No

Key Financial Metrics

Is VSEEW Expensive or Cheap?

P/E Ratio

VSEEW trades at -0.55 times earnings. This suggests potential undervaluation.

-0.55

PEG Ratio

When adjusting for growth, VSEEW's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values VSee Health, Inc. at 1.17 times its book value. This may indicate undervaluation.

1.17

EV/EBITDA

Enterprise value stands at -0.26 times EBITDA. This is generally considered low.

-0.26

How Well Does VSEEW Make Money?

Net Profit Margin

For every $100 in sales, VSee Health, Inc. keeps $-92.37 as profit after all expenses.

-92.37%

Operating Margin

Core operations generate -66.23 in profit for every $100 in revenue, before interest and taxes.

-66.23%

ROE

Management delivers $-115.71 in profit for every $100 of shareholder equity.

-115.71%

ROA

VSee Health, Inc. generates $-70.22 in profit for every $100 in assets, demonstrating efficient asset deployment.

-70.22%

Following the Money - Real Cash Generation

Operating Cash Flow

VSee Health, Inc. generates limited operating cash flow of $-3.19M, signaling weaker underlying cash strength.

$-3.19M

Free Cash Flow

VSee Health, Inc. generates weak or negative free cash flow of $-3.22M, restricting financial flexibility.

$-3.22M

FCF Per Share

Each share generates $-0.11 in free cash annually.

$-0.11

FCF Yield

VSEEW converts -2.20% of its market value into free cash.

-2.20%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.55

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.17

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.17

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.26

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.41

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-115.71

vs 25 benchmark

ROA

Return on assets percentage

-0.70

vs 25 benchmark

ROCE

Return on capital employed

-1.33

vs 25 benchmark

How VSEEW Stacks Against Its Sector Peers

MetricVSEEW ValueSector AveragePerformance
P/E Ratio-0.5529.20 Better (Cheaper)
ROE-11570.74%729.00% Weak
Net Margin-92.37%-52856.00% (disorted) Weak
Debt/Equity0.260.49 Strong (Low Leverage)
Current Ratio0.414.43 Weak Liquidity
ROA-70.22%-20711.00% (disorted) Weak

VSEEW outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews VSee Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

123.91%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-32688.22%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-1172.67%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ